Exact Sciences
EXAS
#1154
Rank
$19.17 B
Marketcap
$101.06
Share price
-0.07%
Change (1 day)
61.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -$5.32

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$5.32. In 2024 the company made an earnings per share (EPS) of -$5.57.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$5.32-4.49%
2024-$5.57
2022-$3.542.31%
2021-$3.46-38.54%
2020-$5.63692.96%
2019-$0.71-50.69%
2018-$1.4444%
2017-$1.00-39.39%
2016-$1.65-2.94%
2015-$1.7037.1%
2014-$1.2479.71%
2013-$0.69-21.59%
2012-$0.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-$4.33-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
$0.34-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
$0.39-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-$50.90 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$3.71-169.66%๐Ÿ‡ซ๐Ÿ‡ท France